COVID-19 and Dexamethasone: A Potential Strategy to Avoid Steroid-Related Strongyloides Hyperinfection

Viewpoint suggests clinicians and healthcare systems should consider implementing strategy to prevent hyperinfection syndrome in patients with COVID-19 who are at risk for strongyloidiasis and are candidates for dexamethasone. It proposes algorithm for assessing and managing risk


Journal of the American Medical Association